Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Metabolic Genetics

Management and Therapies: The Mitochondrial Cocktail and Beyond

At a Glance

Managing Leigh syndrome focuses on supporting cellular energy using a customized 'mitochondrial cocktail' of vitamins and cofactors. It is critical to establish an emergency ER protocol for IV dextrose during illnesses and to strictly avoid mitochondria-toxic medications like Valproic acid and Propofol.

Managing Leigh syndrome currently focuses on supporting the body’s energy production and protecting the brain during times of stress. While there is no universal cure, a combination of specialized supplements and tailored care can help optimize health [1][2].

The “Mitochondrial Cocktail”

Most patients with Leigh syndrome are prescribed a customized mix of vitamins and cofactors known as the mitochondrial cocktail. The goal is to provide the “power plants” (mitochondria) with extra tools to help them produce fuel (ATP) more efficiently [2][3].

Common ingredients include:

  • Coenzyme Q10 (CoQ10): Helps move energy through the production line in the mitochondria [2].
  • L-carnitine: Assists in transporting fatty acids into the mitochondria to be used as fuel [2].
  • Thiamine (B1) and Riboflavin (B2): These act as essential “spark plugs” for the enzymes that drive energy production [2][4].

A Note on Evidence: It is important to know that while many doctors recommend these cocktails based on historical success and biochemical logic, there is a lack of high-quality clinical trials to prove they work for everyone [2][5]. Doses will be tailored based on specific needs [2].

Targeted Treatments for Specific Genes

In some rare cases, finding the exact genetic mutation opens the door to a highly effective treatment:

  • Biotin-Thiamine-Responsive Basal Ganglia Disease (SLC19A3): If this specific mutation is present, high doses of biotin and thiamine are critical and can significantly improve outcomes [4][6].
  • PDHC Deficiency: For this type, a ketogenic diet (high-fat, low-carbohydrate) and high-dose thiamine may be the primary recommendation to help the body bypass the broken energy pathway [7][8].
  • SQOR Deficiency: This rare variant can sometimes be managed with a sulfur-restricted diet and specific medications to reduce toxic buildup in the cells [9][10].

Medical Emergencies and Contraindicated Medications

During illnesses, patients with Leigh syndrome are at high risk for a catabolic crisis, where the body starts breaking down its own tissues for energy.

  • The Emergency Protocol Letter: You should work with your metabolic geneticist to create an Emergency ER Letter. This letter must explicitly state that in the event of vomiting, diarrhea, or fasting due to illness, the patient requires immediate IV fluids containing dextrose (such as D10) to provide the brain with readily available glucose and prevent a severe metabolic crash [2][10].
  • High-Risk Medications: Certain common medications are “mitochondria-toxic” and can trigger severe complications or fatal liver failure. You must proactively flag these to any new doctor or ER staff. The most notable offenders are the anti-seizure medication Valproic acid (Depakote) and the anesthetic Propofol [11][12].

The Horizon: Experimental and Emerging Therapies

Research is moving quickly toward “disease-modifying” treatments that aim to fix the underlying problem rather than just managing symptoms.

  • Vatiquinone (EPI-743): This experimental drug is being studied for its ability to reduce cellular stress and potentially slow the progression of the disease [13][14].
  • Gene Therapy: Scientists are working on using harmless viruses (AAV) to deliver healthy copies of genes, like SURF1, directly into a patient’s cells [15][16].

Common questions in this guide

What is the mitochondrial cocktail for Leigh syndrome?
The mitochondrial cocktail is a customized mix of vitamins and cofactors, including CoQ10, L-carnitine, and thiamine. It is designed to provide your cellular power plants with extra tools to produce energy more efficiently.
Why do I need an emergency protocol letter for Leigh syndrome?
During illnesses involving vomiting, diarrhea, or fasting, patients are at high risk for a severe metabolic crash. An emergency letter tells ER staff to immediately provide IV fluids containing dextrose (D10) to protect the brain and stabilize energy levels.
Are there specific medications I should avoid with Leigh syndrome?
Yes, certain common medications are toxic to mitochondria and can cause severe complications or liver failure. You must proactively alert all doctors to avoid the anti-seizure medication Valproic acid (Depakote) and the anesthetic Propofol.
Can a ketogenic diet help treat Leigh syndrome?
For certain genetic mutations, like PDHC deficiency, a high-fat, low-carbohydrate ketogenic diet may be recommended. This specialized diet helps the body bypass broken energy pathways to successfully produce fuel.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is this specific mutation one of the 'treatable' types, such as PDHC deficiency or a biotin-thiamine responsive disorder?
  2. 2.Which specific supplements in the 'Mito Cocktail' are most likely to provide a benefit based on the genetic diagnosis?
  3. 3.What are the risks and benefits of the ketogenic diet for this particular form of Leigh syndrome?
  4. 4.Can we develop an Emergency Protocol letter to ensure rapid metabolic stabilization with IV dextrose (D10) during illnesses?
  5. 5.Are there any specific medications, like Valproic acid or Propofol, that must be absolutely avoided?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Pediatric mitochondrial diseases and the heart.

    Enns GM

    Current opinion in pediatrics 2017; (29(5)):541-551 doi:10.1097/MOP.0000000000000535.

    PMID: 28719387
  2. 2

    Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines.

    Barcelos I, Shadiack E, Ganetzky RD, Falk MJ

    Current opinion in pediatrics 2020; (32(6)):707-718 doi:10.1097/MOP.0000000000000954.

    PMID: 33105273
  3. 3

    NDUFV1-Related Mitochondrial Complex-1 Disorders: A Retrospective Case Series and Literature Review.

    Mahesan A, Choudhary PK, Kamila G, et al.

    Pediatric neurology 2024; (155()):91-103 doi:10.1016/j.pediatrneurol.2024.02.012.

    PMID: 38626668
  4. 4

    [Paroxysmal crying and motor regression for more than two months in an infant].

    Wen YX, Wang JP, Chen Y, Bao XH

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(4)):399-404.

    PMID: 31014436
  5. 5

    Health Care for Mitochondrial Disorders in Canada: A Survey of Physicians.

    Paik K, Lines MA, Chakraborty P, et al.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2019; (46(6)):717-726 doi:10.1017/cjn.2019.240.

    PMID: 31387656
  6. 6

    Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia.

    Oommen AT, Polavarapu K, Christopher R, Netravathi M

    Neurology India 2022; (70(2)):733-736 doi:10.4103/0028-3886.344659.

    PMID: 35532649
  7. 7

    Schizophrenia-like symptoms in a patient with Leigh syndrome.

    Satogami K, Takahashi S, Kose A, Shinosaki K

    Asian journal of psychiatry 2017; (25()):249-250 doi:10.1016/j.ajp.2016.12.012.

    PMID: 28262162
  8. 8

    Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.

    Bornstein R, James K, Stokes J, et al.

    Neurobiology of disease 2022; (163()):105594 doi:10.1016/j.nbd.2021.105594.

    PMID: 34933094
  9. 9

    Pathogenic variants in SQOR encoding sulfide:quinone oxidoreductase are a potentially treatable cause of Leigh disease.

    Friederich MW, Elias AF, Kuster A, et al.

    Journal of inherited metabolic disease 2020; (43(5)):1024-1036 doi:10.1002/jimd.12232.

    PMID: 32160317
  10. 10

    Exclusion of sulfide:quinone oxidoreductase from mitochondria causes Leigh-like disease in mice by impairing sulfide metabolism.

    Kanemaru E, Shimoda K, Marutani E, et al.

    The Journal of clinical investigation 2024; (134(15)).

    PMID: 38870029
  11. 11

    Endocrine Manifestations and New Developments in Mitochondrial Disease.

    Ng YS, Lim AZ, Panagiotou G, et al.

    Endocrine reviews 2022; (43(3)):583-609 doi:10.1210/endrev/bnab036.

    PMID: 35552684
  12. 12

    Mitochondrial Leigh syndrome: the state of the art.

    Toutain G, Hoebeke C, Gastaldi M, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2025; (32(8)):509-516 doi:10.1016/j.arcped.2025.04.007.

    PMID: 41193338
  13. 13

    Evaluating the efficacy of vatiquinone in preclinical models of mitochondrial disease.

    Kayser EB, Chen Y, Mulholland M, et al.

    Research square 2024; doi:10.21203/rs.3.rs-4202689/v1.

    PMID: 38883711
  14. 14

    Japanese Leigh syndrome case treated with EPI-743.

    Kouga T, Takagi M, Miyauchi A, et al.

    Brain & development 2018; (40(2)):145-149 doi:10.1016/j.braindev.2017.08.005.

    PMID: 28916229
  15. 15

    Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome.

    Ling Q, Rioux M, Hu Y, et al.

    Molecular therapy. Methods & clinical development 2021; (23()):158-168 doi:10.1016/j.omtm.2021.09.001.

    PMID: 34703839
  16. 16

    AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives.

    Hanaford AR, Cho YJ, Nakai H

    Orphanet journal of rare diseases 2022; (17(1)):217 doi:10.1186/s13023-022-02324-7.

    PMID: 35668433

This page explains therapies and emergency management strategies for Leigh syndrome for educational purposes. Always consult your metabolic geneticist before adjusting your mitochondrial cocktail, diet, or emergency medical protocol.

Get notified when new evidence is published on Leigh syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.